Shanghai Mediumbank Biotechnology Co.
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- $16M
Investors
- 2
About Shanghai Mediumbank Biotechnology Co.
, Ltd. is a biotech company that engages in the research and development, production, and sale of cell culture medium. The company's customers cover a variety of biomedical companies, such as monoclonal antibodies, fusion proteins, vaccines, IVDs, etc. In 2021, the company established the first phase production base that has been put into production and is establishing the second phase production base in 2022. And the company's products has passed the quality management certification, ISO13485. The company developed six cell culture mediums, including CHO cells culture medium, hybridoma and myeloma cells culture medium, HEK293 cells culture medium, insect cells culture medium, virus vaccine cells culture medium, and T cells and stem cells culture medium. Those products can be applied to biological drug research and development, clinical applications and commodities chemical production and other stages. The company also provides solutions, including standard products, culture mediums optimization and development, process optimization, serum-free suspension acclimation, and medium supernatant analysis.
Who invested in Shanghai Mediumbank Biotechnology Co.
2 investors across 1 round
See all investors in Shanghai Mediumbank Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 15, 2022
Amount
$16M
Investors
Questions about Shanghai Mediumbank Biotechnology Co.
Who invested in Shanghai Mediumbank Biotechnology Co.?
Shanghai Mediumbank Biotechnology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Mediumbank Biotechnology Co. raised?
Shanghai Mediumbank Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanghai Mediumbank Biotechnology Co. last raise money?
Shanghai Mediumbank Biotechnology Co.'s most recent round on record is a Series B, in Apr 2022.
What does Shanghai Mediumbank Biotechnology Co. do?
Shanghai Mediumbank Biotechnology Co. is a biotechnology company.
Where is Shanghai Mediumbank Biotechnology Co. headquartered?
Shanghai Mediumbank Biotechnology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Mediumbank Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Shanghai Mediumbank Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shanghai Mediumbank Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.